Axa S.A. Arbutus Biopharma Corp Transaction History

Axa S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$5.0 - $7.35 $2.68 Million - $3.94 Million	-535,644 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$4.4 - $6.05 $24,156 - $33,214	-5,490 Reduced 1.01%	535,644 $2.68 Million
Q4 2017 Feb 13, 2018	SELL	$4.45 - $7.7 $151,896 - $262,831	-34,134 Reduced 5.93%	541,134 $2.73 Million
Q3 2017 Nov 13, 2017	BUY	$3.4 - $7.0 $1.96 Million - $4.03 Million	575,268	575,268 $3.57 Million

138

95.5M

3.44M

377K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $577M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.